Chlamydia and Gonorrhea MDx Test from Abbott Cleared by FDA

Jun 28, 2010

NEW YORK (GenomeWeb News) – Abbott today announced it has received 510(k) clearance from the US Food and Drug Administration for its molecular diagnostic test and instrument for detecting gonorrhea and chlamydia, including a new strain of chlamydia recently discovered in Sweden.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Same Old Error

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

Own Merits

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Back to Neanderthals

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

PNAS Papers on Small Molecule From Soil Bacteria, Circulating Tumor Cell Chip, More

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.

Featured White Papers

Anchored Multiplex PCR Enables Sensitive NGS-based Mutation Detection and Design Flexibility for FFPE Samples

Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinomas Show a Marked Increase in PDL1 Expression Relative to Viral Negative Tumors

Vetting a Contract Manufacturing Partner for Your Clinical Diagnostics Kit

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Jul

14

Featured Webinar

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul

15

Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul

22

Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul

23

Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Menu

Chlamydia and Gonorrhea MDx Test from Abbott Cleared by FDA

To read the full story....

Breaking News

GenMark Diagnostics Preliminary Q2 Revenues Rise 118 Percent on SARS-CoV-2 Tests

Sequencing Study Reveals Role of RIPOR2 Mutation in Adult-Onset Hearing Loss

Progenity Asks Court to Declare Non-Infringement of Natera Patents

FDA Issues New Guidance for SARS-CoV-2 Pooled Sample Testing

Computational Tools Help Predict Efficiency, Outcomes of Base Editors

Exome Analysis of Southwestern American Indians Highlights Metabolic Disease-Linked Variants

The Scan

Same Old Error

Own Merits

Back to Neanderthals

PNAS Papers on Small Molecule From Soil Bacteria, Circulating Tumor Cell Chip, More

Featured White Papers

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

Sponsorships